Back

Heart failure medical therapy and outcomes in patients undergoing transcatheter mitral valve repair for secondary mitral regurgitation: a TVT Registry analysis across 449 US centers

26 August 2023 (13:30 - 13:45)
Organised by: Logo
Congress Presentation Part of: Young Investigator Awards Session in Heart Failure Mitral Valve Regurgitation ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Anubodh Varshney

Stanford University School of Medicine, Palo Alto (United States of America)

2 More presentations in this session

Presentation thumbnail
DNA methylation profiling of circulating CD4+ T cells and network analysis reveal that JUNB, SETD7, and MEF2D genes predict patients with heart failure preserved vs. reduced ejection fraction
Doctor G. Benincasa (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Polygenic risk score for hypertrophic cardiomyopathy predicts population disease risk, penetrance in sarcomeric rare variant carriers and survival in cases
Doctor S. Zheng (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Awards Session in Heart Failure
Video

The Event

Event poster

ESC Congress 2023

26 August 2023 13:30 CET
You may be interested in
thumbnail
Congress Presentation
A greater number of guideline-directed medical therapy was associated with improvement of the prognosis after mitral transcatheter edge-to-edge repair - insight from OCEAN-Mitral Registry-
thumbnail
Congress Session
Young Investigator Awards Session in Heart Failure
thumbnail
Congress Session
Insights from recent HFrEF trials 2

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources